Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CHEVREAU, C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 85

  • Page / 4
Export

Selection :

  • and

Les effets secondaires des anti-angiogéniques (à l'exception des effets cutanés) : Actualités et perspectives dans le cancer du rein = Side effects of anti-angiogenics (not including cutaneous effects)CHEVREAU, C.Oncologie (Paris). 2009, Vol 11, Num 5, pp 285-290, issn 1292-3818, 6 p.Article

Traitement de rattrapage des tumeurs germinales : Testicules: formes graves et mauvais pronostics = Treatment of relapse in germ cell tumor patientsCHEVREAU, C.Correspondances en onco-urologie. 2011, Vol 2, Num 2, pp 82-84, issn 2110-087X, 3 p.Article

Traitement standard des formes de mauvais pronostic : chimiothérapie conventionnelle = Conventional chemotherapy of high risk testicular cancerCHEVREAU, C.Pathologie et biologie. 1994, Vol 42, Num 10, pp 992-993, issn 0369-8114Conference Paper

Le ganglion sentinelle = Sentinel lymph nodeCHEVREAU, C; BONEU, A.Oncologie (Paris). 2000, Vol 2, Num 1, pp 39-44, issn 1292-3818Article

Chimiothérapie anticancéreuse et fertilité masculine = Cancer chemotherapy and fertility in menCHEVREAU, C; HUGUET, F.Andrologie (Lille). 1995, Vol 5, Num 4, pp 458-464, issn 1166-2654Conference Paper

Deuxième ligneGUILLOT, A; CHEVREAU, C.Correspondances en onco-urologie. 2014, Vol 5, Num 2, pp 72-74, issn 2110-087X, 3 p.Article

EXPERIENCE DE LA VENTILATION SPONTANEE EN PRESSION EXPIRATOIRE POSITIVE EN REANIMATION CHIRURGICALE POLYVALENTEPICARD JM; JACOB F; CHEVREAU C et al.1981; ANN. ANESTHESIOL. FR.; ISSN 0003-4061; FRA; DA. 1981; VOL. 22; NO 5; PP. 423-427; BIBL. 27 REF.Conference Paper

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)GARBAY, D; LE CESNE, A; COLLARD, O et al.Annals of oncology. 2012, Vol 23, Num 1, pp 182-186, issn 0923-7534, 5 p.Article

Management and outcome of metastatic melanoma during pregnancyPAGES, C; ROBERT, C; KHAMMARI, A et al.British journal of dermatology (1951). 2010, Vol 162, Num 2, pp 274-281, issn 0007-0963, 8 p.Article

Les mélanomes du tronc ont-ils un pronostic individualisable ? A propos d'une série de 77 cas = An individuatized prognosis for truncal melanoma? A series of 77 casesMARTEL, P; GARRIDO, I; FERRON, G et al.Bulletin du cancer. 2010, Vol 97, Num 8, pp 901-907, issn 0007-4551, 7 p.Article

Detection of local recurrences of limb soft tissue sarcomas: Is magnetic resonance imaging (MRI) relevant? : Imaging of Soft Tissue Sarcomas IILABARRE, D; AZIZA, R; FILLERON, T et al.European journal of radiology. 2009, Vol 72, Num 1, pp 50-53, issn 0720-048X, 4 p.Article

A limited sampling strategy for determining carboplatin AUC and monitoring drug dosageCHATELUT, E; PIVOT, X; OTTO, J et al.European journal of cancer (1990). 2000, Vol 36, Num 2, pp 264-269, issn 0959-8049Article

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma: A Federation Nationale des Centres de Lutte contre le Cancer Multicenter, Parallel StudyDORVAL, T; NEGRIER, S; ESCUDIER, B et al.Cancer. 1999, Vol 85, Num 5, pp 1060-1066, issn 0008-543XArticle

Expression of MAGE genes in primary and metastatic cutaneous melanomaBRASSEUR, F; RIMOLDI, D; VACCA, A et al.International journal of cancer. 1995, Vol 63, Num 3, pp 375-380, issn 0020-7136Article

High-dose interleukin-2 two days a week for metastatic renal cell carcinoma : a FNCLCCC multicenter studyESCUDIER, B; RAVAUD, A; FARACE, F et al.Journal of immunotherapy with emphasis on tumor immunology. 1994, Vol 16, Num 4, pp 306-312, issn 1067-5582Article

Prise en charge du tératome pur testiculaire postpubertaire à propos d'une série multicentrique sur 15 ans = Management of pure teratoma of the testis in adult, results of a multicenter study over 15 yearsLABARTHE, P; KHEDIS, M; HOULGATTE, A et al.Progrès en urologie (Paris). 2008, Vol 18, Num 13, pp 1075-1081, issn 1166-7087, 7 p.Article

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors : a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)CULINE, S; KERBRAT, P; BIRON, P et al.Annals of oncology. 2007, Vol 18, Num 5, pp 917-924, issn 0923-7534, 8 p.Article

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'ImmunothérapieNEGRIER, S; ESCUDIER, B; GOMEZ, F et al.Annals of oncology. 2002, Vol 13, Num 9, pp 1460-1468, issn 0923-7534, 9 p.Article

Cytokines in metastatic renal cell carcinoma : Is it useful to switch to Interleukin-2 or interferon after failure of a first treatment?ESCUDIER, B; CHEVREAU, C; SAVARY, J et al.Journal of clinical oncology. 1999, Vol 17, Num 7, pp 2039-2043, issn 0732-183XArticle

Population pharmacokinetics of total and unbound etoposideNGUYEN, L; CHATELUT, E; CHEVREAU, C et al.Cancer chemotherapy and pharmacology. 1998, Vol 41, Num 2, pp 125-132, issn 0344-5704Article

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma : A multicenter phase II trialRAVAUD, A; AUDHUY, B; LINASSIER, C et al.Journal of clinical oncology. 1998, Vol 16, Num 8, pp 2728-2732, issn 0732-183XArticle

A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancerCHATELUT, E; CHEVREAU, C; BRUNNER, V et al.Cancer chemotherapy and pharmacology. 1995, Vol 35, Num 5, pp 391-396, issn 0344-5704Article

Prediction of carboplatin clearance from standard morphological and biological patient characteristicsCHATELUT, E; CANAL, P; BRUNNER, V et al.Journal of the National Cancer Institute. 1995, Vol 87, Num 8, pp 573-580, issn 0027-8874Article

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours : preliminary results of a French randomized trial. DiscussionCHEVREAU, C; DROZ, J. P; BOUZY, J et al.CHEVREAU, C; European urology. 1993, Vol 23, Num 1, pp 213-218, issn 0302-2838Conference Paper

Cardiotoxicity of high-dose continuous infusion fluorouracil : a prospective clinical studyDE FORNI, M; MALET-MARTINO, M. C; ROCHE, H et al.Journal of clinical oncology. 1992, Vol 10, Num 11, pp 1795-1801, issn 0732-183XArticle

  • Page / 4